Eton Pharmaceuticals Overview
Latest P/E ratio for Eton Pharmaceuticals: 119.05 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow119.05
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, ETON shows a P/E ratio of 119.05. That is above the Healthcare sector average of 25.72. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 25.72. Eton Pharmaceuticals is at 119.05, which is higher that average. That is roughly 362.9% above the sector mean. Use the comparison chart on this page to see how ETON stacks up against individual peers as well.
Investors watch ETON's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Eton Pharmaceuticals's latest reading is 119.05. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Eton Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 119.05) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 25.72, while ETON is at 119.05. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
